Accéder au contenu
Merck

Targeted Protein Degradation by Small Molecules.

Annual review of pharmacology and toxicology (2016-10-13)
Daniel P Bondeson, Craig M Crews
RÉSUMÉ

Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of disease-relevant proteins. Here, we review recent advances in the use of small molecules to degrade proteins in a selective manner. First, we highlight all-small-molecule techniques with direct clinical application. Second, we describe techniques that may find broader acceptance in the biomedical research community that require little or no synthetic chemistry. In addition to serving as innovative research tools, these new approaches to control intracellular protein levels offer the potential to develop novel therapeutics targeting proteins that are not currently pharmaceutically vulnerable.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Pomalidomide-4-piperidine-C1-piperazine hydrochloride
Sigma-Aldrich
Pomalidomide-piperidine-carboxylic acid, ≥95%
Sigma-Aldrich
1-Piperazinecarboxylic acid, 4-(4-piperidinyl)-, 1,1-dimethylethyl ester, ≥98%
Sigma-Aldrich
(S,R,S)-AHPC-C9-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-benzyl-piperazine hydrochloride
Sigma-Aldrich
C5 Lenalidomide-benzyl-piperazine hydrochloride
Sigma-Aldrich
4-Aminomethyl-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione hydrochloride, ≥95%
Sigma-Aldrich
VH032-OH, ≥95%
Sigma-Aldrich
Pomalidomide-piperazine-C1-4-piperidine hydrochloride
Sigma-Aldrich
Pomalidomide-piperazine-piperidine-4-carboxamide hydrochloride
Sigma-Aldrich
VH032-cyclopropane-F, ≥95%
Sigma-Aldrich
Pomalidomide-C2-NH2 hydrochloride, ≥95%
Sigma-Aldrich
CCW16, ≥95%
Sigma-Aldrich
4-(Aminoethyl)-1-N-Boc-piperidine, ≥95.0%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-C2-NH2 hydrochloride
Sigma-Aldrich
Pomalidomide-PEG2-C2-NH2 hydrochloride, ≥95%
Sigma-Aldrich
Carbamic acid, N-[2-(1-piperazinyl)ethyl]-, 1,1-dimethylethyl ester, ≥95%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-C3-piperazine hydrochloride
Sigma-Aldrich
(S,R,S)-AHPC-benzyl-piperazine hydrochloride
Sigma-Aldrich
Pomalidomide-PEG1-C2-amine HCl, ≥95.0%
Sigma-Aldrich
Thalidomide-4-hydroxyacetate, ≥95.0%
Sigma-Aldrich
Pomalidomide 4′-PEG3-amine hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-methylamino-PEG1-NH2 hydrochloride
Sigma-Aldrich
2-(2,6-dioxopiperidin-3-yl)-5-(piperidin-4-yl)isoindole-1,3-dione hydrochloride, ≥95%
Sigma-Aldrich
2,6-Piperidinedione, 3-[(3-aminophenyl)amino] hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-piperazine-pyridine-alkyne-NH2 hydrochloride
Sigma-Aldrich
Pomalidomide-piperazine-acetic acid, ≥95%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-piperazine-pyridine-alkyne-NH2 hydrochloride
Sigma-Aldrich
VH 032 amide-alkyl C3-acid, ≥95%
Sigma-Aldrich
C5-Pomalidomide-piperazine hydrochloride, ≥95%